WHWK
WHITEHAWK THERAPEUTICS, INC.
Company Overview
Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.
SectorHealthcare
IndustryBiotechnology
Market Cap$262.2M
Employees32
CEODavid J. Lennon
Websitehttps://ir.whitehawktx.com
Valuation
Current Price$4.6
Fair Value?$000.00
Valuation?No valuation
Hist. PE ?N/Aⓘ
EPS (TTM) ?-0.96
Forward EPS Growth ?—
Historical Growth ?58.88%
Equity, FCF, Long Term Debt, Net Profit, and Shares Outstanding history charts are available on the Pro plan for just $9.99/month.Sign in to unlock Pro
Price
EPS
Revenue
Equity
ProAvailable on the Pro plan
Free Cash Flow
ProAvailable on the Pro plan
Long Term Debt
ProAvailable on the Pro plan
Net Profit
ProAvailable on the Pro plan
Shares Outstanding
ProAvailable on the Pro plan
Last updated: 9/5/2026, 7:02:04 PM